Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cocktail of human mAbs targeting the henipavirus fusion and receptor binding proteins provides cross-species neutralization.

Science translational medicine·2026
Same author

Repurposing Clinical Candidates for Nipah and Hendra Viruses.

ACS infectious diseases·2026
Same author

Efficacy of the nucleoside analog 4'-Fluorouridine against Nipah virus in the Syrian hamster model.

PLoS pathogens·2026
Same author

De novo recovery of Ghana virus, an African bat Henipavirus, reveals differential tropism and attenuated pathogenicity compared to Nipah virus.

Cell reports·2026
Same author

LRP8 is an entry receptor for tick-borne encephalitis viruses.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Fertility preservation for cancer: referral guidelines, treatment options, and specific considerations.

Fertility and sterility·2025

Related Experiment Video

Updated: Oct 17, 2025

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.2K

Recent advances in combating Nipah virus.

Kendra Johnson1, Michelle Vu1, Alexander N Freiberg2

  • 1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.

Faculty Reviews
|October 11, 2021
PubMed
Summary
This summary is machine-generated.

Nipah virus (NiV) is a dangerous bat-borne virus causing severe human illness and economic losses. This review discusses progress in developing crucial therapeutic treatments for NiV infection.

Keywords:
Nipah virusantibodiesantiviralsencephalitishenipavirusrespiratory disease

More Related Videos

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
10:16

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

Published on: October 30, 2021

3.9K
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.5K

Related Experiment Videos

Last Updated: Oct 17, 2025

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.2K
High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
10:16

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

Published on: October 30, 2021

3.9K
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.5K

Area of Science:

  • Virology
  • Zoonotic Diseases
  • Public Health

Background:

  • Nipah virus (NiV) is a highly pathogenic bat-borne paramyxovirus responsible for severe respiratory disease and encephalitis in humans.
  • Human-to-human transmission of NiV has been confirmed in multiple outbreaks, posing a significant public health threat.
  • NiV also infects various mammals, including agricultural species, leading to substantial economic consequences.

Purpose of the Study:

  • To review the current progress in developing therapeutic measures against Nipah virus infection.
  • To highlight the urgent need for effective treatments due to NiV's severity and pandemic potential.

Main Methods:

  • Literature review of published research on Nipah virus.
  • Analysis of therapeutic strategies and drug development pipelines for NiV.

Main Results:

  • Nipah virus remains a global health priority due to its high mortality rate and lack of approved treatments.
  • Ongoing research focuses on antiviral therapies, vaccines, and supportive care strategies.

Conclusions:

  • Development of effective therapeutics for Nipah virus is critical to prevent future pandemics.
  • Continued research and international collaboration are essential for NiV countermeasures.